On February 11, 2026, Junzheng Zhang acquired shares of IMMUNOTECH-B (06978) via an off-exchange transaction, specifically through a waiver of rights over shares/debentures, which is not a direct secondary-market dealing.
Prior to the acquisition, Junzheng Zhang's long position in IMMUNOTECH-B was 43.76 million shares, representing 7.09%; following the acquisition, the holding changed to 50.76 million shares, with the long position ratio rising to 8.22%.